Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

439 Views

Session: Out With the Old, in With the New: Time to Update the Management of Staphylococcus aureus Infections

144 - Should Vancomycin Be Replaced in the MRSA Guidelines? - Pro

Monday, October 20, 2025

2:03 PM - 2:21 PM US ET

Location: Ballroom (Hall B1)

Debate Style Speaker(s)

Carlo Tascini, MD (he/him/his)

First class Professor
University of Udine
Udine, Italy

Slides

Disclosure(s):

Carlo Tascini, MD: A. Menarini Industrie Farmaceutiche Riunite S.R.L.: Honoraria; AdvanzPharma: Advisor/Consultant, Honoraria; Angelini: Honoraria; Beckman-Coulter: Honoraria; Biotest: Honoraria; DiaSorin: Honoraria; Gilead: Honoraria; Hikma: Advisor/Consultant, Honoraria; INFECTOPHARM: Honoraria; Merck, Sharpe & Dohme: Advisor/Consultant, Honoraria; Pfizer, Inc.: Advisor/Consultant, Honoraria; Thermo Fisher, Inc.: Advisor/Consultant, Honoraria; Viatris: Advisor/Consultant, Honoraria